New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354
Multidrug-resistant pathogens pose a serious threat to human health. For decades, the antibiotic vancomycin has been a potent option when treating Gram-positive multidrug-resistant infections. Nonetheless, in recent decades, we have begun to see an increase in vancomycin-resistant bacteria. Here, we...
Saved in:
Main Authors: | Iliana E Escobar (Author), Alexis White (Author), Wooseong Kim (Author), Eleftherios Mylonakis (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antimicrobial Peptides Targeting Gram-Positive Bacteria
by: Nermina Malanovic, et al.
Published: (2016) -
Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria
by: Kathryn L. Nawrocki, et al.
Published: (2014) -
Tetracycline improved the efficiency of other antimicrobials against Gram-negative multidrug-resistant bacteria
by: Isabelle K. Mawabo, et al.
Published: (2015) -
Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
by: Daniele Roberto Giacobbe, et al.
Published: (2020) -
Antimicrobial Quantitative Relationship and Mechanism of Plant Flavonoids to Gram-Positive Bacteria
by: Ganjun Yuan, et al.
Published: (2022)